Nomsa Musemwa1, Crystal A Gadegbeku2. 1. Department of Medicine, Division of Nephrology, Hypertension and Kidney Transplantation, Temple University School of Medicine, Kresge West, Suite 100, 3440 North Broad Street, Philadelphia, PA, 19140, USA. 2. Department of Medicine, Division of Nephrology, Hypertension and Kidney Transplantation, Temple University School of Medicine, Kresge West, Suite 100, 3440 North Broad Street, Philadelphia, PA, 19140, USA. crystal.gadegbeku@tuhs.temple.edu.
Abstract
PURPOSE OF REVIEW: African Americans are over-burdened with hypertension resulting in excess morbidity and mortality. We highlight the health impact of hypertension in this population, review important observations regarding disease pathogenesis, and outline evidence-based treatment, current treatment guidelines, and management approaches. RECENT FINDINGS: Hypertension accounts for 50% of the racial differences in mortality between Blacks and Whites in the USA. Genome-wide association studies have not clearly identified distinct genetic causes for the excess burden in this population as yet. Pathophysiology is complex likely involving interaction of genetic, biological, and social factors prevalent among African Americans. Non-pharmacologic and pharmacologic therapy is required and specific treatment guidelines for this population are varied. Combination therapy is most often necessary and single-pill formulations are most successful in achieving BP targets. Racial health disparities related to hypertension in African Americans are a serious public health concern that warrants greater attention. Multi-disciplinary research to understand the inter-relationship between biological and social factors is needed to guide successful treatments. Comprehensive care strategies are required to successfully address and eliminate the hypertension burden.
PURPOSE OF REVIEW: African Americans are over-burdened with hypertension resulting in excess morbidity and mortality. We highlight the health impact of hypertension in this population, review important observations regarding disease pathogenesis, and outline evidence-based treatment, current treatment guidelines, and management approaches. RECENT FINDINGS:Hypertension accounts for 50% of the racial differences in mortality between Blacks and Whites in the USA. Genome-wide association studies have not clearly identified distinct genetic causes for the excess burden in this population as yet. Pathophysiology is complex likely involving interaction of genetic, biological, and social factors prevalent among African Americans. Non-pharmacologic and pharmacologic therapy is required and specific treatment guidelines for this population are varied. Combination therapy is most often necessary and single-pill formulations are most successful in achieving BP targets. Racial health disparities related to hypertension in African Americans are a serious public health concern that warrants greater attention. Multi-disciplinary research to understand the inter-relationship between biological and social factors is needed to guide successful treatments. Comprehensive care strategies are required to successfully address and eliminate the hypertension burden.
Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: C W Yancy; M B Fowler; W S Colucci; E M Gilbert; M R Bristow; J N Cohn; M A Lukas; S T Young; M Packer Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245
Authors: David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey Journal: Hypertension Date: 2008-04-07 Impact factor: 10.190
Authors: Lindsay Fernández-Rhodes; Kristin L Young; Adam G Lilly; Laura M Raffield; Heather M Highland; Genevieve L Wojcik; Cary Agler; Shelly-Ann M Love; Samson Okello; Lauren E Petty; Mariaelisa Graff; Jennifer E Below; Kimon Divaris; Kari E North Journal: Circ Res Date: 2020-06-04 Impact factor: 17.367
Authors: Robert H Schneider; Clarence Grim; Theodore Kotchen; Komal Marwaha; Jane Kotchen; John W Salerno; Carolyn Gaylord King; Sanford Nidich; Charles N Alexander Journal: Am J Prev Cardiol Date: 2021-10-04
Authors: M Maffoni; S Traversoni; E Costa; L Midão; P Kardas; M Kurczewska-Michalak; A Giardini Journal: Eur Geriatr Med Date: 2020-03-30 Impact factor: 1.710
Authors: Oyunbileg Magvanjav; Rhonda M Cooper-DeHoff; Caitrin W McDonough; Yan Gong; Mark S Segal; William R Hogan; Julie A Johnson Journal: J Clin Hypertens (Greenwich) Date: 2018-11-14 Impact factor: 3.738
Authors: Agus Surachman; Alexis R Santos; Jonathan K Daw; Lacy Alexander; David M Almeida; Christopher L Coe Journal: Psychoneuroendocrinology Date: 2021-05-29 Impact factor: 4.693
Authors: Michelle C Johansen; Paul Nyquist; Kevin J Sullivan; Myriam Fornage; Rebecca F Gottesman; Diane M Becker Journal: Neuroepidemiology Date: 2021-06-17 Impact factor: 5.393
Authors: Arnaud D Kaze; Solomon K Musani; Aurelian Bidulescu; Adolfo Correa; Sherita H Golden; Alain G Bertoni; Justin B Echouffo-Tcheugui Journal: Am J Hypertens Date: 2021-11-20 Impact factor: 3.080